Finn Partners Taps Industry Leader Kristie Kuhl As Senior Partner, Health

Appointment Reflects Firm's Continued Health Sector Growth

News provided by

Oct 13, 2015, 09:00 ET

NEW YORK, Oct. 13, 2015 /PRNewswire/ -- Finn Partners announced today that Kristie Kuhl has been appointed senior partner, Health. Kuhl will champion the practice's pharmaceutical efforts focusing on biotechnology, pharmaceutical, specialty pharma and orphan drug clients. The hire affirms Finn Partners' commitment to becoming a global leader in health communications in sectors that influence patient access to care. Kuhl reports to Gil Bashe, managing partner, and global health practice director, Finn Partners

Kristie Kuhl, Senior Partner, Health, Finn Partners

Finn Partners Logo

"Kristie has been on the frontlines addressing reimbursement, pricing, drug approvals and patient advocacy concerns, and helping clients navigate the social media landscape and other issues that dominate planning urgencies," said Bashe.

He also noted that in her role as senior partner, and with a law degree, Kuhl is sensitive to the regulatory environment – critical to navigating the health landscape – and offers insight in helping communicators and marketers understand the diverse interests of payers, policymakers, providers and advocacy groups to create a unifying focus around patient access to medication. Bashe added, "Clients have tapped her to lead numerous agency brand communications campaigns. Additionally, she is a noted pioneer on biosimilars and orphan drugs communications."

"Pharma companies – dominant players and entrepreneurs – face an increasingly complex reimbursement environment while patients, advocates and the physicians seek simplicity. Communicators need to help make access the default action," said Kuhl. "Collaboration – drawing upon the interests of diverse health sectors to improve patient wellbeing – is a focus that fits nicely with Finn Partners' values."

Prior to joining Finn Partners, Kuhl served as executive vice president at both Cohn & Wolfe and Makovsky & Company.

Kuhl has been in the forefront of many award-winning campaigns for blockbuster pharmaceutical products that reach millions and orphan drugs that improve the lives of thousands. A standing commitment to make a difference in health, Kuhl volunteers within the patient community. She is on the CancerCare Walk/Run for Hope Committee and in 2016, she will serve on the ASCO Conquer Cancer Foundation Development Committee.

About Finn Partners, Inc.

Finn Partners was launched in late 2011 to realize Peter Finn's vision to create a leading communications agency dedicated to shaping a bold new future in which innovation and partnership are strong drivers of the brand. Finn Partners specializes in the full spectrum of communications services, including digital and social media. Specialty areas include technology, consumer, education, travel & lifestyle, CSR, arts, health, and public and corporate affairs.

Finn Partners was named "Best Midsize Agency" in 2015, "Best Agency to Work For" in 2013 and "Best New Agency" in 2012 by the industry's Holmes Report. Headquartered in New York City, the company has approximately 500 employees, with offices in Chicago, Detroit, Fort Lauderdale, Jerusalem, London, Los Angeles, Munich, Nashville, Paris, San Francisco and Washington D.C., and has additional international capabilities through its own global network and PROI Worldwide. Find us at www.finnpartners.com and follow us on Twitter @finnpartners.